Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance

This publication has 110 references indexed in Scilit:

• Combined Model of Intrinsic and Extrinsic Variability for Computational Network Design with Application to Synthetic Biology
  PLOS Computational Biology, 2013
• Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients
  Chronobiology International, 2011
• The circadian mutation PER2S662G is linked to cell cycle progression and tumorigenesis
  Cell Death & Differentiation, 2011
• Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
  The Lancet Oncology, 2011
• Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial
  Annals of Oncology, 2010
• The population genetics of mutations: good, bad and indifferent
  Philosophical Transactions of the Royal Society B: Biological Sciences, 2010
• The genetics of mammalian circadian order and disorder: implications for physiology and disease
  Nature Reviews Genetics, 2008
• Tumor chronobiology
  Journal of Controlled Release, 2001
• Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
  The Lancet, 1997
• Analytical solutions of the dinucleotide probability after and before random mutations
  Journal of Theoretical Biology, 1995